| 前收盘价格 | 7.57 |
| 收盘价格 | 7.40 |
| 成交量 | 1,095,315 |
| 平均成交量 (3个月) | 2,701,836 |
| 市值 | 539,406,464 |
| 价格/销量 (P/S) | 1.25 |
| 股市价格/股市净资产 (P/B) | 0.820 |
| 52周波幅 | |
| 利润日期 | 28 Jul 2025 - 1 Aug 2025 |
| 营业毛利率 | -10.92% |
| 营业利益率 (TTM) | 37.82% |
| 稀释每股收益 (EPS TTM) | -0.660 |
| 季度收入增长率 (YOY) | 646.20% |
| 总债务/股东权益 (D/E MRQ) | 1.59% |
| 流动比率 (MRQ) | 4.58 |
| 营业现金流 (OCF TTM) | -250.70 M |
| 杠杆自由现金流 (LFCF TTM) | -2.69 M |
| 资产报酬率 (ROA TTM) | -5.39% |
| 股东权益报酬率 (ROE TTM) | -7.34% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Arvinas, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
0.9
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.88 |
|
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 6.75% |
| 机构持股比例 | 86.56% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| New Leaf Venture Partners, L.L.C. | 31 Mar 2025 | 1,585,721 |
| Nextech Invest, Ltd. | 31 Mar 2025 | 1,408,394 |
| Nextech Invest Ltd. | 31 Dec 2024 | 1,408,394 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 24.00 (HC Wainwright & Co., 224.76%) | 购买 |
| 中 | 11.00 (48.85%) | |
| 低 | 8.00 (Goldman Sachs, 8.25%) | 保留 |
| 平均值 | 13.73 (85.79%) | |
| 总计 | 7 购买, 6 保留 | |
| 平均价格@调整类型 | 7.47 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Leerink Partners | 02 Jun 2025 | 9.00 (21.79%) | 保留 | 7.33 |
| UBS | 15 May 2025 | 21.00 (184.17%) | 购买 | 6.26 |
| Morgan Stanley | 09 May 2025 | 11.00 (48.85%) | 保留 | 6.61 |
| BMO Capital | 05 May 2025 | 10.00 (35.32%) | 购买 | 7.63 |
| Citigroup | 05 May 2025 | 9.50 (28.55%) | 保留 | 7.63 |
| Truist Securities | 05 May 2025 | 11.00 (48.85%) | 保留 | 7.63 |
| 09 Apr 2025 | 21.00 (184.17%) | 购买 | 6.73 | |
| Barclays | 02 May 2025 | 16.00 (116.51%) | 购买 | 7.72 |
| Goldman Sachs | 02 May 2025 | 8.00 (8.25%) | 保留 | 7.72 |
| 17 Apr 2025 | 12.00 (62.38%) | 保留 | 8.60 | |
| Guggenheim | 02 May 2025 | 16.00 (116.51%) | 购买 | 7.72 |
| HC Wainwright & Co. | 02 May 2025 | 24.00 (224.76%) | 购买 | 7.72 |
| 07 Apr 2025 | 81.00 (996.08%) | 购买 | 6.37 | |
| Jefferies | 02 May 2025 | 10.00 (35.32%) | 保留 | 7.72 |
| Piper Sandler | 02 May 2025 | 14.00 (89.45%) | 购买 | 7.72 |
| Wells Fargo | 02 May 2025 | 19.00 (157.10%) | 购买 | 7.72 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合